AFX.DE Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 16:23):

Stats
Dzisiejszy wolumen	12 967.00
Średni wolumen	131 971
Kapitalizacja rynkowa	9.00B
EPS	€0 ( 2024-02-09 )
Następna data zysków	( €0.880 ) 2024-05-07
Last Dividend	€1.100 ( 2023-03-23 )
Next Dividend	€0 ( N/A )
P/E	32.45
ATR14	€0.0760 (0.08%)

Wolumen Korelacja

Długi: -0.22 (neutral)

Krótki: -0.46 (neutral)

Signal:(43.555) Neutral

Carl Zeiss Meditec AG Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Carl Zeiss Meditec AG Korelacja - Waluta/Towar

-0.27
( neutral )

-0.28
( neutral )

0.00
( neutral )

-0.14
( neutral )

0.08
( neutral )

0.34
( neutral )

Carl Zeiss Meditec AG Finanse

Annual	2023
Przychody:	€2.09B
Zysk brutto:	€1.21B (57.71 %)
EPS:	€3.25

FY	2023
Przychody:	€2.09B
Zysk brutto:	€1.21B (57.71 %)
EPS:	€3.25

FY	2022
Przychody:	€1.90B
Zysk brutto:	€1.13B (59.26 %)
EPS:	€3.29

FY	2021
Przychody:	€1.65B
Zysk brutto:	€967.21M (58.73 %)
EPS:	€2.64

Financial Reports:

No articles found.

Carl Zeiss Meditec AG Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
€0 (N/A)	€0 (N/A)	€1.100 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)

Carl Zeiss Meditec AG Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.69 - low (22.66%) | Divividend Growth Potential Score: 4.66 - Stable (6.90%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	€0.117	2006-03-13
Last Dividend	€1.100	2023-03-23
Next Dividend	€0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	19	--
Total Paid Out	€8.36	--
Avg. Dividend % Per Year	0.00%	--
Score	1.94	--
Div. Sustainability Score	3.69
Div.Growth Potential Score	4.66
Div. Directional Score	4.17	--

Next Divdend (Est)
(2024-12-17)

€0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

1.94

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for XETRA

Symbol	Title	Last dividend	Frequency	Yearly Dividend
VVD.DE	Ex Dividend Knight	2023-05-09	Annually	0.00%
EVK.DE	Ex Dividend Junior	2023-06-01	Annually	0.00%
OMV.DE	Ex Dividend Knight	2023-06-06	Annually	0.00%
AMG.DE	Ex Dividend Knight	2023-08-17	Quarterly	0.00%
HAW.DE	Ex Dividend Junior	2023-06-13	Annually	0.00%
RIO1.DE	Ex Dividend Knight	2023-08-10	Semi-Annually	0.00%
BST.DE	Ex Dividend Junior	2023-09-14	Sporadic	0.00%
JNJ.DE	Ex Dividend Knight	2023-08-25	Quarterly	0.00%
TA1.DE	Ex Dividend Knight	2023-06-12	Annually	0.00%
DEF.DE	Ex Dividend Knight	2023-07-24	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.132	1.500	7.36	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.134	1.500	9.62	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	24.02	1.000	2.22	2.22	[3 - 30]
operatingCashFlowPerShareTTM	2.62	2.00	9.13	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.345	2.00	9.33	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.573	1.000	3.78	3.78	[0.2 - 0.8]
operatingProfitMarginTTM	0.196	1.000	8.08	8.08	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.69

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	32.27	1.000	6.84	0	[1 - 100]
returnOnEquityTTM	0.134	2.50	9.76	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.345	2.00	9.55	10.00	[0 - 30]
dividendYielPercentageTTM	1.097	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	2.62	2.00	9.13	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-3.17	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.112	1.000	9.71	0	[0.1 - 0.5]
Total Score				4.66

Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries. It serves practicing ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, dental and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.